Thar Pharma seeks $50M IPO to develop drug for chronic pain
Thar produces an oral version of an existing intravenous drug used to treat the estimated 80,000 Americans diagnosed annually with complex regional pain syndrome.
Drug reformulation company raising $2 million to advance cancer treatment
A pharmaceutical company reformulating intravenous drugs into orally administered medication is raising a little more than $2 million to advance a cancer drug, according to an amended Form D filing with the U.S. Securities and Exchange Commission. Thar Pharmaceuticals’ strategy offers several advantages, primarily that it makes the drug development process much cheaper and less […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Cancer drug developer Thar Pharmaceuticals adds to series A
Thar Pharmaceuticals has added a $250,000 investment to its series A round as the cancer drug developer looks to continue clinical trials, according to a regulatory document. Pittsburgh, Pennsylvania-based Thar is aiming for a series A round of up to $9.6 million, CEO Ray Houck said in January. Houck didn’t respond to an inquiry last […]
Drug reformulation firm Thar Pharmaceuticals raises $4.3M
Drug reformulation company Thar Pharmaceuticals has raised $4.3 million in investment funding, according to a regulatory filing. The Pittsburgh company's lead product is a reformulation of an unspecified IV cancer drug. The company's reformulated drug "should have fewer side effects and save up to $3,900 per patient per year in IV administration costs," according to its website. The company plans to begin a Phase 2 trial of the drug this year.
Pittsburgh’s Thar Pharmaceuticals raises $1.2M
Thar Pharmaceuticals Inc. has raised $1.2 million in debt financing to commercialize drugs based on supercritical fluid technologies, according to a regulatory filing.